Inventor · disambiguated record
Thomas Prisinzano
Also filed as: PRISINZANO THOMAS · PRISINZANO THOMAS E · PRISINZANO THOMAS EDWARD
13 granted patents·3 pending applications·17 citations·filing 2005–2022
86Inventor score
Top patents by PatentIndex Score
16 records- 0186US10118896B2Antagonists of the kappa opioid receptorUNIV KANSAS·Filed 2015·Granted Nov 6, 2018·4 cites·18 claims
- 0283US11324742B2Treatment of demyelinating diseasesVICTORIA LINK LTD·Filed 2020·Granted May 10, 2022·2 cites·21 claims
- 0382US9540375B2Kappa opioid receptor effectors and uses thereofUNIV KANSAS·Filed 2016·Granted Jan 10, 2017·4 cites·2 claims
- 0480US7728001B2Opioid receptor ligands and methods for their preparationUNIV IOWA RES FOUND·Filed 2005·Granted Jun 1, 2010·3 cites·19 claims
- 0579US10125129B2Agonists of the mu opioid receptorUNIV KANSAS·Filed 2017·Granted Nov 13, 2018·2 cites·20 claims
- 0672US12318380B2Treatment of demyelinating diseasesVICTORIA LINK LTD·Filed 2022·Granted Jun 3, 2025·0 cites·15 claims
- 0770US9345703B2Kappa opioid receptor effectors and uses thereofAUBE JEFFREY·Filed 2012·Granted May 24, 2016·1 cites·5 claims
- 0864US9428494B2Therapeutic compoundsPRISINZANO THOMAS·Filed 2007·Granted Aug 30, 2016·1 cites·2 claims
- 0962US11987564B2PTPRD inhibitors and uses thereofUS GOV VETERANS AFFAIRS·Filed 2022·Granted May 21, 2024·0 cites·16 claims
- 1060US10829453B2Antagonists of the kappa opioid receptorUNIV KANSAS·Filed 2018·Granted Nov 10, 2020·0 cites·11 claims
- 1160US2021015813A1Treatment of demyelinating diseasesVICTORIA LINK LTD·Filed 2019·Application pending·0 cites
- 1248US9868730B2Kappa opioid receptor selective compounds, compositions, and uses thereofJAVITCH JONATHAN·Filed 2014·Granted Jan 16, 2018·0 cites·11 claims
- 1345US2009088466A1Opioid receptor ligandsUNIV IOWA RES FOUND·Filed 2006·Application pending·0 cites
- 1444US11034679B2Agonists of the mu opioid receptorUNIV KANSAS·Filed 2018·Granted Jun 15, 2021·0 cites·16 claims
- 1539US9416103B2Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseasesUNIV ARKANSAS·Filed 2013·Granted Aug 16, 2016·0 cites·15 claims
- 1638US2021023074A1Treatment of demyelinating diseasesVICTORIA LINK LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Prisinzano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →